Abstract
The present study aimed at describing the outcome of patients with HIV-associated lymphomas following autologous hematopoietic stem cell transplantation (autoHCT) in the rituximab and combined antiretroviral therapy (cART) era. Eligible for this retrospective study were HIV-positive patients with lymphoma who received autoHCT between 2007 and 2013. A total of 118 patients were included with a median age of 45 years (range 24-66). Underlying diagnoses were diffuse large B cell lymphoma in 47%, Hodgkin lymphoma in 24%, Burkitt lymphoma in 18%, and plasmablastic lymphoma in 7% of patients. Disease status at autoHCT was complete remission in 44%, partial remission (PR) in 38%, and less than PR in 18% of the patients. With a median follow-up of 4 years, 3-year non-relapse mortality, incidence of relapse, progression-free survival (PFS) and overall survival (OS) were 10%, 27%, 63% and 66%, respectively. By multivariate analysis, disease status less than PR but not CD4+ cell count at the time of autoHCT was a significant predictor of unfavorable PFS and OS. In conclusion, in the era of cART and chemoimmunotherapy, the outcome of autoHCT for HIV-related lymphoma is driven by lymphoma-dependent risk factors rather than by characteristic...Continue Reading
References
Apr 1, 2000·Lancet·J GabarreV Leblond
Sep 25, 2004·Blood·Amrita KrishnanStephen J Forman
Jun 9, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A JostingA Engert
Aug 19, 2006·Blood·Robert J BiggarEric A Engels
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas PowlesMark Bower
Mar 25, 2009·Blood·José L Díez-MartínUNKNOWN European Group for Blood and Marrow Transplantation Lymphoma Working Party
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pascual BalsalobreAnna Sureda
Apr 13, 2011·Journal of the National Cancer Institute·Meredith S ShielsEric A Engels
Oct 19, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicolas MounierUNKNOWN Lymphoma Working Party of European Blood and Marrow Transplantation Registry (EBMT)
Jun 26, 2012·Current Opinion in Oncology·James J Goedert, Mark Bower
Oct 10, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Silvia MontotoMark Bower
Jan 31, 2013·Cancer·Josep-Maria RiberaTeresa Bernal
Jan 15, 2014·AIDS·Rita CoutinhoMark Bower
Jun 6, 2014·AIDS·Philippe MorlatUNKNOWN ANRS EN20 Mortalité 2010 Study Group
Jul 11, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mehdi HamadaniEdmund K Waller
Sep 4, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D A EichenauerUNKNOWN ESMO Guidelines Working Group
Nov 19, 2014·British Journal of Haematology·Philipp SchommersChristoph Wyen
Mar 19, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Chiara CattaneoPeter Dreger
Mar 24, 2015·Bone Marrow Transplantation·A SuredaA Madrigal
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H TillyUNKNOWN ESMO Guidelines Committee
Nov 17, 2015·Bone Marrow Transplantation·L SellnerUNKNOWN EBMT Lymphoma Working Party
Dec 1, 2015·Bone Marrow Transplantation·S P RobinsonP Dreger
Jun 15, 2016·Blood·Joseph C AlvarnasRichard Ambinder
Sep 7, 2016·Bone Marrow Transplantation·R RamaswamiM Bower
Mar 3, 2017·Oncology Research and Treatment·Tanya WelzManfred Hensel
Oct 11, 2017·Bone Marrow Transplantation·A ReG Rossi
Feb 14, 2018·Haematologica·Philipp SchommersChristian Hoffmann